Objective To study parvovirus B19 infection in immunocompromised subjects such as renal
transplantation recipients. Methods Two cases of B19 infection in renal transplant recipients …

To evaluate the occurrence and clinical role of active parvovirus B19 infection in solid organ
and bone marrow transplant recipients, 256 serum samples from 212 transplant patients …

Renal transplant patients were screened for the presence of parvovirus B19, before
transplantation and monthly for 4 months after transplantation, by means of a sensitive …

Background Parvovirus B19 presents tropism for human erythroid progenitor cells, causing
chronic anemia in organ transplant recipients, due to their suppressed humoral and cellular …

Parvovirus B19 infection is s new viral threat in post-kidney transplantation. It is a viral
infection often acquired from the donor, occurring in young transplant patients during the first …

Organ transplant recipients infected with parvovirus B19 frequently develop persistent
viremia associated with chronic anemia and pure red cell aplasia. In this study, a male renal …

Background. Parvovirus B19 (B19) infection is known to cause chronic infection leading to
anemia in immunocompromised patients. Although nosocomial B19 infections in …

Human parvovirus B19 (B19) infection has been known to cause chronic anemia, pure red
cell aplasia (PRCA), glomerulopathy, and allograft dysfunction in kidney transplant (KT) …

Background. The frequency of B19 infection in renal transplant donors and recipients was
studied to determine the significance of active viral infection in the development of anemia …

Human parvovirus B19 can persist in immunocompromised patients and may produce
severe clinical illness. In this retrospective study the incidence of B19-associated infections …